Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H


Primary Symbol: BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Post by neinsteinon Aug 27, 2015 10:36am
209 Views
Post# 24055761

TSX Listing versus TSX Venture

TSX Listing versus TSX VentureI do not believe Bioasis currently meets the minimum listing requirements for the senior exchange however the question is will Bioasis meet those requirements in the coming weeks and months? If they do Bioasis will undoubtedly move to the TSX as soon as the paaperwork can be filed. Cash flow and capital in treasury seem to be key.

If so the next question is do you want to own the stock before or after that happens? Before or after licensing deals (and TAAs) contribute to the cash flow and treasury requirements? 

For those of you curious as to the various requirements:

https://www.blakesfiles.com/Guides/Blakes_Going_Public_TSX_TSXV_in_Canada_EN.pdf. Appendix A.

nein
Bullboard Posts